Diagnosis and treatment of gestational trophoblastic neoplasia
Xing Xie
Abstract
Xing Xie
Abstract
Gestational trophoblastic neoplasia (GTN) includes invasive mole and choriocarcinoma. Before the discovery of effective chemotherapeutic agents for human chorionic gonadotropin (HCG), the survival prognosis for the patients with the disease was very poor. At present, with the setup of sensitive quantitative assays and new drugs to be developed for HCG, most women with GTN can be cured and their reproductive function preserved. The purpose of this paper is to address current opinions regarding the diagnosis, staging, and management of GTN.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Gestational trophoblastic neoplasia (GTN) includes invasive mole and choriocarcinoma. Before the discovery of effective chemotherapeutic agents for human chorionic gonadotropin (HCG), the survival prognosis for the patients with the disease was very poor. At present, with the setup of sensitive quantitative assays and new drugs to be developed for HCG, most women with GTN can be cured and their reproductive function preserved. The purpose of this paper is to address current opinions regarding the diagnosis, staging, and management of GTN.
Key concepts: Gestational trophoblastic neoplasia, Choriocarcinoma, Human chorionic gonadotropin, Gestational trophoblastic disease, Medicine, Trophoblastic neoplasm, Placental site trophoblastic tumor, Gynecology